Back

Appetitive Pavlovian goal-tracking memory reconsolidation is reduced by both adrenergic and NMDA receptor antagonism

Lee, J.

2026-06-28 neuroscience
10.64898/2026.06.23.733991 bioRxiv
Show abstract

RationaleAppetitive Pavlovian cues can drive maladaptive reward seeking via stimulus-reward memories. Disrupting memory reconsolidation offers a potential strategy to reduce their influence, but evidence for {beta}-adrenergic blockade with propranolol is inconsistent across behavioural paradigms, particularly relative to NMDA receptor antagonism. ObjectivesWe tested whether propranolol disrupts reconsolidation of appetitive sucrose memories in a discriminative goal-tracking paradigm, and compared its effects with those of the most commonly used NMDA receptor antagonist, MK-801. MethodsAdult Lister hooded rats underwent discriminative Pavlovian conditioning. Thirty minutes before a brief memory reminder (non-reinforced or reinforced), rats received systemic drug treatment or saline control. In study 1, MK-801 (0.1 mg/kg) was administered to male rats. In study 2, propranolol (10 mg/kg) was administered to equal numbers of male and female rats. Goal-tracking was tested drug-free at 1 and 8 days. ResultsIn study 1, MK-801 impaired subsequent discriminated responding at test. These effects were observed not only when reminder was non-reinforced as in previous successful demonstrations, but also with reinforced reminder. In study 2, Propranolol also impaired subsequent goal-tracking, regardless of reminder type, and the effects were consistent across sexes. ConclusionsPropranolol can disrupt reconsolidation of appetitive goal-tracking memories to a similar extent as MK-801 under conditions that promote memory destabilisation. These findings demonstrate that {beta}-adrenergic blockade can impair appetitive memory reconsolidation in a goal-tracking paradigm, challenging prior null findings and revitalising the potential for propranolol-based interventions in maladaptive reward-seeking behaviours.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Psychopharmacology
69 papers in training set
Top 0.1%
34.5%
2
Behavioural Brain Research
77 papers in training set
Top 0.1%
7.9%
3
Neurobiology of Learning and Memory
40 papers in training set
Top 0.1%
5.6%
4
Neuropsychopharmacology
153 papers in training set
Top 0.7%
4.4%
50% of probability mass above
5
PLOS ONE
5266 papers in training set
Top 36%
3.4%
6
Hormones and Behavior
45 papers in training set
Top 0.1%
3.4%
7
Behavioral Neuroscience
25 papers in training set
Top 0.1%
3.2%
8
Scientific Reports
3612 papers in training set
Top 35%
3.2%
9
Journal of Psychopharmacology
17 papers in training set
Top 0.1%
2.5%
10
The Journal of Neuroscience
1025 papers in training set
Top 7%
2.0%
11
Neuropharmacology
68 papers in training set
Top 0.5%
1.7%
12
Frontiers in Behavioral Neuroscience
49 papers in training set
Top 0.5%
1.7%
13
International Journal of Neuropsychopharmacology
14 papers in training set
Top 0.2%
1.5%
14
Progress in Neuro-Psychopharmacology and Biological Psychiatry
48 papers in training set
Top 0.6%
1.5%
15
eneuro
439 papers in training set
Top 5%
1.4%
16
Brain and Behavior
43 papers in training set
Top 0.8%
1.4%
17
Psychophysiology
77 papers in training set
Top 1%
1.0%
18
Learning & Memory
23 papers in training set
Top 0.2%
1.0%
19
Translational Psychiatry
260 papers in training set
Top 4%
0.8%
20
Addiction Neuroscience
17 papers in training set
Top 0.4%
0.8%
21
Drug and Alcohol Dependence
41 papers in training set
Top 0.5%
0.8%
22
Pharmacology Biochemistry and Behavior
17 papers in training set
Top 0.3%
0.8%
23
eLife
5828 papers in training set
Top 65%
0.8%
24
Hippocampus
56 papers in training set
Top 0.7%
0.6%